Toggle light / dark theme

DDW Editor Reece Armstrong speaks to Ellie Mahjubi, Vice President, Protein and cell analysis at Thermo Fisher Scientific, about how spatial biology is impacting drug discovery and development research.

RA: What’s the future and potential for spatial biology?

EM: Technological advancements in spatial biology are providing unprecedented insights into single cells within their spatial context, facilitating the analysis of cell types, functional states, cell interaction networks, as well as tissue microenvironments and architecture. These innovations promise to significantly advance basic research and enhance our understanding of human health and disease.

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.

The authors at King’s College London say that using the radiotracer—an injected compound used in PET scans—could help inform doctors that a patient’s aggressive cancer will not respond to chemotherapy before treatment is given. This would prevent patients receiving unnecessary treatment and provide them with alternative options that will give them the best chance of beating the disease.

The paper, “Imaging NRF2 activation in non-small cell lung cancer with published in Nature Communications, shows therapy-resistant tumors “lit up like a Christmas tree” on PET scans when the radiotracer was injected.

Sign up for the Morning Brief email newsletter to get weekday updates from The Weather Channel and our meteorologists.

A powerful earthquake, possibly the strongest in years, has devastated the island nation of Vanuatu, killing at least 14 people. More than 200 are reported injured according to a post on X by Katie Greenwood, Fiji-based head of the Red Cross in the Pacific.

The 7.3-magnitude jolt rocked the region on Tuesday sending tremors through homes, businesses and critical infrastructure. Witnesses described buildings collapsing, roads blocked by landslides and hospitals stretched thin as reports of injuries — and unconfirmed casualties — surfaced.

Dr. Ethell’s groundbreaking research serves as the foundation for Leucadia Therapeutics’ work. A PhD in Neuroscience, he has studied Alzheimer’s disease for 20 years. He was a Human Frontiers of Science Long-term Fellow at the Max Planck Institute for Psychiatry in Germany and a Research Associate at the Scripps Research Institute in La Jolla, California. Dr. Ethell ran Alzheimer’s disease research at the La Jolla Institute for Immunology, served on the faculty at the University of California Riverside, and later founded the Molecular Neurobiology Group at the Western University of Health Sciences in Pomona, California, where he also chaired the Department of Neuroscience. He has authored more than 85 papers and presentations.

The Coalition for Radical Life Extension and Longevity Escape Velocity Foundation are bringing together the best in longevity research with the best in anti-aging and age-reversal practices.
The critical research Aubrey de Grey Ph.D. has curated through his renowned Longevity Summit will now be featured at RAADfest, alongside the most advanced and relevant clinical practices for impacting longevity today. RAADfest is the largest and most immersive event in the world focused on super-longevity for a general audience.

Bringing together cutting-edge science, inspiration, entertainment and fun, RAADfest is more than just a conference – it’s a celebration of life. RAADfest provides the information and inspiration to enable people to take charge of their longevity. Produced by the Coalition for Radical Life Extension, whose mission is to align people, resources and policies to our shared vision of curing aging.
https://www.raadfest.com/

Unlocking The Potential Of Blood — Dr. Jackie Kunzler Ph.D. — Senior Vice President, Global R&D, Terumo Blood and Cell Technologies.


Dr. Jackie Kunzler, Ph.D. is Senior Vice President and Global Head of Research and Development (R&D), and member of the Executive Management Committee, of Terumo Blood and Cell Technologies (https://www.terumobct.com/), where she focuses on innovation and development leading the way for unlocking the potential of blood and cell collections in varied sectors, including blood banking, plasma-based therapies and cell and gene therapies.

Dr. Kunzler joined Terumo from Baxter Healthcare where she held successive leadership roles in their business, including as Baxter Healthcare’s Senior Vice President for Quality and Regulatory and Head of Global Life Sciences.

A research team led by Professor Kim Kyuhyung at the Department of Brain Sciences, DGIST, has discovered a new principle that regulates how food moves through the digestive tract and is swallowed. They found that the Piezo channel proteins sense the pressure generated when food accumulates at the front of the digestive tract, triggering swallowing behavior.

This discovery is expected to provide important clues in developing treatments for digestive and eating disorders. The work is published in the journal Nature Communications.

When we eat, the digestive tract generates various signals that can be linked to important physiological processes. However, our understanding of how the movement and accumulation of food in the digestive tract are sensed and processed to regulate important behaviors like swallowing remains limited.

Just as a conductor coordinates different instruments in an orchestra to produce a symphony, breathing coordinates hippocampal brain waves to strengthen memory while we sleep, reports a new Northwestern Medicine study.

This is the first time breathing rhythms during sleep have been linked to these hippocampal brain waves—called slow waves, spindles and ripples—in humans. Scientists knew these waves were linked to memory but their underlying driver was unknown. The study is published in the Proceedings of the National Academy of Sciences.

“To strengthen memories, three special neural oscillations emerge and synchronize in the hippocampus during sleep, but they were thought to come and go at random times,” said senior study author Christina Zelano, professor of neurology at Northwestern University Feinberg School of Medicine. “We discovered that they are coordinated by breathing rhythms.”

Nearly a quarter of Portuguese adults have allergies that cause a runny nose. This respiratory disease, formally called allergic rhinitis and frequently associated with asthma, is a common problem around the world, and the upper airway is a key target for research into the underlying disease processes.

Now a global team of researchers has discovered that patients with allergy-induced sniffles and asthma have different fungal colonies or mycobiomes in their noses, suggesting potential lines of inquiry for future treatments.

“We showed that samples displayed a significantly higher fungal diversity and a different fungal community structure compared to those of healthy controls,” said Dr. Luís Delgado of the University of Porto, Portugal, one of the authors of the article in Frontiers in Microbiology. “This may suggest that allergic rhinitis increases the diversity and changes the composition of the upper airway’s microbiome.”

Glyphosate use in the United States (US) has increased each year since the introduction of glyphosate-tolerant crops in 1996, yet little is known about its effects on the brain. We recently found that C57BL/6J mice dosed with glyphosate for 14 days showed glyphosate and its major metabolite aminomethylphosphonic acid present in brain tissue, with corresponding increases in pro-inflammatory cytokine tumor necrosis factor-⍺ (TNF-⍺) in the brain and peripheral blood plasma. Since TNF-⍺ is elevated in neurodegenerative disorders such as Alzheimer’s Disease (AD), in this study, we asked whether glyphosate exposure serves as an accelerant of AD pathogenesis. Additionally, whether glyphosate and aminomethylphosphonic acid remain in the brain after a recovery period has yet to be examined.

We hypothesized that glyphosate exposure would induce neuroinflammation in control mice, while exacerbating neuroinflammation in AD mice, causing elevated Amyloid-β and tau pathology and worsening spatial cognition after recovery. We dosed 4.5-month-old 3xTg-AD and non-transgenic (NonTg) control mice with either 0, 50 or 500 mg/kg of glyphosate daily for 13 weeks followed by a 6-month recovery period.

We found that aminomethylphosphonic acid was detectable in the brains of 3xTg-AD and NonTg glyphosate-dosed mice despite the 6-month recovery. Glyphosate-dosed 3xTg-AD mice showed reduced survival, increased thigmotaxia in the Morris water maze, significant increases in the beta secretase enzyme (BACE-1) of amyloidogenic processing, amyloid-β (Aβ) 42 insoluble fractions, Aβ 42 plaque load and plaque size, and phosphorylated tau (pTau) at epitopes Threonine 181, Serine 396, and AT8 (Serine 202, Threonine 205). Notably, we found increased pro-and anti-inflammatory cytokines and chemokines persisting in both 3xTg-AD and NonTg brain tissue and in 3xTg-AD peripheral blood plasma.

Objective: Intermittent energy restriction (IER) is an effective weight loss strategy. However, little is known about the dynamic effects of IER on the brain-gut-microbiome axis.

Methods: In this study, a total of 25 obese individuals successfully lost weight after a 2-month IER intervention. FMRI was used to determine the activity of brain regions. Metagenomic sequencing was performed to identify differentially abundant gut microbes and pathways in from fecal samples.

Results: Our results showed that IER longitudinally reduced the activity of obese-related brain regions at different timepoints, including the inferior frontal orbital gyrus in the cognitive control circuit, the putamen in the emotion and learning circuit, and the anterior cingulate cortex in the sensory circuit. IER longitudinally reduced E. coli abundance across multiple timepoints while elevating the abundance of obesity-related Faecalibacterium prausnitzii, Parabacteroides distasonis, and Bacterokles uniformis. Correlation analysis revealed longitudinally correlations between gut bacteria abundance alterations and brain activity changes.